Horst Lindhofer
- Oncology top 1%
- CAR-T cell therapy research 28
-
- Monoclonal and Polyclonal Antibodies Research 54
- Immunology top 2%
- Immunotherapy and Immune Responses 31
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 12
- Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment 8
-
- Intraperitoneal and Appendiceal Malignancies 14
-
- Cancer Research and Treatments 8
-
- Lymphoma Diagnosis and Treatment 8
- Co-authors
- Peter RufCarsten BokemeyerDiane SeimetzMichael JägerM. M. HeissRalph MocikatAlexander BurgesPauline Wimberger
- Journals
- Journal of Clinical Oncology (24 papers)International Journal of Cancer (6 papers)Cancer Research (5 papers)
- Partner nations
- GermanyUnited KingdomSwitzerland
In The Last Decade
Horst Lindhofer
94 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 2.0k
- Radiology, Nuclear Medicine and Imaging 1.7k
- Immunology 1.4k
- Reproductive Medicine 385
- Gastroenterology 113
Countries citing papers authored by Horst Lindhofer
This map shows the geographic impact of Horst Lindhofer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Horst Lindhofer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Horst Lindhofer more than expected).
Fields of papers citing papers by Horst Lindhofer
This network shows the impact of papers produced by Horst Lindhofer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Horst Lindhofer. The network helps show where Horst Lindhofer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Horst Lindhofer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 7 | |
| 3 | 2021 | 16 | |
| 4 | 2018 | 66 | |
| 5 | 2015 | 13 | |
| 6 | 2013 | 14 | |
| 7 | 2013 | 8 | |
| 8 | 三官能性抗体Catumaxomab(抗EpCAM×Anti-CD3)による治療を受けた悪性腹水患者の第2/3相試験に関する免疫モニタリング結果 | 2012 | 1 |
| 9 | 2010 | 65 | |
| 10 | 2010 | 112 | |
| 11 | 2010 | 211 | |
| 12 | 2009 | 34 | |
| 13 | 2009 | 44 | |
| 14 | 2007 | 76 | |
| 15 | 2006 | 139 | |
| 16 | 2006 | 5 | |
| 17 | 2000 | 148 | |
| 18 | 1999 | 16 | |
| 19 | 1995 | 31 | |
| 20 | Effect of fish oil concentrate on the lipoprotein profile in patients suffering from type II diabetes mellitus | 1992 | 2 |
About Horst Lindhofer
Horst Lindhofer is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology, having authored 95 papers that have together received 3.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (54 papers), Immunotherapy and Immune Responses (31 papers), CAR-T cell therapy research (28 papers), Intraperitoneal and Appendiceal Malignancies (14 papers), Ovarian cancer diagnosis and treatment (12 papers), Gastrointestinal Tumor Research and Treatment (8 papers), Cancer Research and Treatments (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). The work is most often cited by research in Oncology (2.0k citations), Radiology, Nuclear Medicine and Imaging (1.7k citations) and Immunology (1.4k citations). Horst Lindhofer has collaborated with scholars based in Germany, United Kingdom and Switzerland. Frequent co-authors include Peter Ruf, Carsten Bokemeyer, Diane Seimetz, Michael Jäger, M. M. Heiss, Ralph Mocikat, Alexander Burges, Pauline Wimberger, S. Thierfelder and A. Schoberth. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Cancer, Cancer Research, Blood and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.